Literature DB >> 33075250

The Unrecognized Prevalence of Primary Aldosteronism.

Anand Vaidya1, Jenifer M Brown1, Robert M Carey2, Mohammed Siddiqui3, Gordon H Williams1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33075250      PMCID： PMC7839832          DOI： 10.7326/L20-1097

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone.

Authors:  R M Carey; J G Douglas; J R Schweikert; G W Liddle
Journal:  Arch Intern Med       Date:  1972-12

2.  Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial.

Authors:  Rajiv Agarwal; Patrick Rossignol; Alain Romero; Dahlia Garza; Martha R Mayo; Suzette Warren; Jia Ma; William B White; Bryan Williams
Journal:  Lancet       Date:  2019-09-15       Impact factor: 79.321

3.  Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.

Authors:  Gregory L Hundemer; Gary C Curhan; Nicholas Yozamp; Molin Wang; Anand Vaidya
Journal:  Lancet Diabetes Endocrinol       Date:  2017-11-09       Impact factor: 32.069

4.  The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study.

Authors:  Jenifer M Brown; Cassianne Robinson-Cohen; Miguel Angel Luque-Fernandez; Matthew A Allison; Rene Baudrand; Joachim H Ix; Bryan Kestenbaum; Ian H de Boer; Anand Vaidya
Journal:  Ann Intern Med       Date:  2017-10-10       Impact factor: 25.391

5.  Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.

Authors:  Bryan Williams; Thomas M MacDonald; Steve V Morant; David J Webb; Peter Sever; Gordon T McInnes; Ian Ford; J Kennedy Cruickshank; Mark J Caulfield; Sandosh Padmanabhan; Isla S Mackenzie; Jackie Salsbury; Morris J Brown
Journal:  Lancet Diabetes Endocrinol       Date:  2018-04-11       Impact factor: 32.069
  5 in total
  1 in total

1.  Trust the Patient: An Unusual Case of Metabolic Alkalosis.

Authors:  Melanie Paige Hoenig; Stewart H Lecker
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-16       Impact factor: 8.237
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.